Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Understanding CSA C22.2 No. 80601-2-61-14 (2019): Pulse Oximeter Safety and Performance Requirements
Comprehensive Guide to the Canadian Medical Electrical Equipment Standard for Pulse Oximeter Devices
Scope and Application
CSA C22.2 No. 80601-2-61-14 (2019) is the Canadian national standard for the basic safety and essential performance of pulse oximeter equipment, part of the CSA C22.2 series of medical electrical standards. It is harmonized with IEC 80601-2-61:2017 and supersedes earlier editions relevant to pulse oximeters used in healthcare facilities, home care, and emergency medical services. The standard applies to any device that non‑invasively estimates oxygen saturation of arterial hemoglobin (SpO₂) and pulse rate, including standalone monitors, handheld devices, and modules integrated into multi‑parameter patient monitors.
The scope excludes laboratory oximeters, tissue oximeters, and devices intended solely for veterinary use. Compliance with CSA C22.2 No. 80601-2-61-14 (2019) is required for sale or installation in Canada and serves as a benchmark for safety, accuracy, and usability in clinical environments.
Tip: This standard is used in conjunction with CSA C22.2 No. 60601-1 (IEC 60601-1) and the applicable collateral standards of the 60601 series. A complete risk management file per ISO 14971 is essential for demonstrating conformity.
Key Technical Requirements
Essential Performance Parameters
The standard defines essential performance as the ability of the pulse oximeter to provide accurate SpO₂ and pulse rate readings under specified conditions. Key performance indicators include accuracy over the clinically relevant range, response time, and robustness against motion artifact and low perfusion.
| Parameter | Requirement | Test Condition |
|---|---|---|
| SpO₂ accuracy (root‑mean‑square error) | ≤ 4% for SpO₂ 70–100% | Controlled hypoxia study with at least 12 subjects (equiv. to ISO 80601-2-61 test) |
| SpO₂ accuracy (low oxygen range) | ≤ 5% for SpO₂ 50–69% | As above, with extended desaturation |
| Pulse rate accuracy (root‑mean‑square error) | ≤ 5 bpm for range 25–250 bpm | Electrocardiographic reference |
| Low‐perfusion performance | SpO₂ error ≤ 4% at 0.5% modulation index | Standardized optical bench test |
| Motion artifact tolerance | SpO₂ error ≤ 5% under defined motion profiles | Proprietary motion test (manufacturer to define) |
Alarm Systems and Safety Features
Alarm conditions—such as high/low SpO₂, pulse rate limits, and sensor disconnect—must comply with IEC 60601-1-8. The standard requires priority classification, visual and audible indicators, and delay times appropriate to clinical urgency. In addition, the equipment shall provide a visual indication of signal quality and a sensor malfunction detection that prevents erroneous assignments.
Warning: Alarms for SpO₂ thresholds must be distinguishable from other physiological alarms. Failure to configure priority levels correctly can lead to alarm fatigue or missed critical events.
Implementation Highlights
Manufacturers integrating CSA C22.2 No. 80601-2-61-14 (2019) into their design process should focus on three areas: sensor design, software verification, and usability engineering. The standard mandates that sensors be validated across a diverse skin‑tone range (Fitzpatrick scale) to minimize bias. Software that processes photoplethysmographic signals must be developed in accordance with IEC 62304. Any proprietary algorithms for artifact rejection or perfusion compensation require documented evidence of performance under the specified test conditions.
Environmental testing—including temperature, humidity, and altitude—follows the rules of IEC 60601‑1. Pulse oximeters intended for transport or home use must also meet additional drop and ingress protection requirements defined in national deviations. Compliance with CSA C22.2 No. 80601-2-61-14 (2019) may be demonstrated through a combination of type testing, risk management documentation, and conformity assessment by a recognized certification body.
Success Path: Early engagement with a testing laboratory familiar with CSA requirements can streamline the certification process. Many facilities accept the IECEE CB Scheme test reports when accompanied by national differences evaluation.
Compliance and Conformity Assessment
The standard is recognized by the Standards Council of Canada (SCC) and referenced by Health Canada for device licensing. To achieve compliance, manufacturers must prepare a technical file containing:
- Risk management report (ISO 14971)
- Essential performance verification data (SpO₂ and pulse rate accuracy)
- Alarm system verification per IEC 60601‑1‑8
- Software lifecycle documentation (IEC 62304)
- Labeling and instructions for use in both English and French
Post‑market surveillance and vigilance reporting follow Canadian Medical Devices Regulations (SOR/98‑282). Any modifications affecting safety or essential performance require re‑evaluation under the current edition.
Important: Using out‑of‑specification pulse oximeters in critical care can contribute to hidden hypoxemia and delayed intervention. Adherence to the accuracy limits and alarm requirements of this standard is not only a regulatory obligation but a patient safety imperative.
As of 2026, the standard remains current; however, manufacturers should monitor CSA announcements for amendments or replacement editions.
Frequently Asked Questions
Q: What devices are excluded from this standard?
A: Devices intended exclusively for veterinary use, laboratory oximeters, tissue oximeters, and pulse oximeters used for non‑medical wellness purposes (i.e., not under professional or prescribed use) are outside the scope.
A: Devices intended exclusively for veterinary use, laboratory oximeters, tissue oximeters, and pulse oximeters used for non‑medical wellness purposes (i.e., not under professional or prescribed use) are outside the scope.
Q: How does CSA C22.2 No. 80601-2-61-14 (2019) relate to IEC 80601-2-61?
A: It is the identical Canadian adoption of IEC 80601-2-61:2017, with specific national deviations covering electrical ratings, bilingual labeling, and temperature limits for the Canadian market.
A: It is the identical Canadian adoption of IEC 80601-2-61:2017, with specific national deviations covering electrical ratings, bilingual labeling, and temperature limits for the Canadian market.
Q: Is there a grace period for compliance?
A: Health Canada requires compliance upon sale or import; however, the transition from earlier editions was aligned with the CSA publication date. Manufacturers should verify with their certification body for any transitional provisions.
A: Health Canada requires compliance upon sale or import; however, the transition from earlier editions was aligned with the CSA publication date. Manufacturers should verify with their certification body for any transitional provisions.
Q: What are the most common non‑conformities found during audits?
A: Incomplete risk management files, insufficient SpO₂ accuracy data for all sensor models, and alarm priority misconfiguration are frequently cited. Software documentation under IEC 62304 also causes recurring issues.
A: Incomplete risk management files, insufficient SpO₂ accuracy data for all sensor models, and alarm priority misconfiguration are frequently cited. Software documentation under IEC 62304 also causes recurring issues.
Document CSA C22.2 No. 80601-2-61-14 (2019) – This article reflects the standard as of 2026. For official requirements, refer to the latest publication from CSA Group.